Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hualan Biological Engineering Chongqing is a prominent subsidiary of Hualan Biological Engineering Inc., specializing in the production and distribution of plasma-derived medicinal products. Based in Chongqing, China, the company operates advanced plasma fractionation facilities that produce essential therapeutics including human albumin, intravenous immunoglobulins, and various coagulation factors. The company plays a vital role in the Chinese healthcare system by providing critical treatments for hemophilia, immunodeficiencies, and emergency care. Hualan Bio Chongqing adheres to strict Good Manufacturing Practice (GMP) standards and leverages sophisticated protein purification technologies to ensure the safety and efficacy of its biological products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hualan Biological Engineering Chongqing.